The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial design.

Inci MG, Sehouli J, Schnura E, Lee M, Roll S, Reinhold T, Klews J, Kaufner L, Niggemann P, Groeben H, Toelkes J, Reisshauer A, Liebl M, Daehnert E, Zimmermann M, Knappe-Drzikova B, Rolker S, Nunier B, Algharably E, Pirmorady Sehouli A, Zwantleitner L, Krull A, Heitz F, Ataseven B, Chekerov R, Harter P, Schneider S

Open source

DOI
10.1136/ijgc-2023-004531
Published
2023 Aug 7
Container
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/ijgc-2023-004531,
  title = {The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial design.},
  author = {Inci MG and Sehouli J and Schnura E and Lee M and Roll S and Reinhold T and Klews J and Kaufner L and Niggemann P and Groeben H and Toelkes J and Reisshauer A and Liebl M and Daehnert E and Zimmermann M and Knappe-Drzikova B and Rolker S and Nunier B and Algharably E and Pirmorady Sehouli A and Zwantleitner L and Krull A and Heitz F and Ataseven B and Chekerov R and Harter P and Schneider S},
  year = {2023},
  journal = {International journal of gynecological cancer : official journal of the International Gynecological Cancer Society},
  doi = {10.1136/ijgc-2023-004531},
  url = {https://doi.org/10.1136/ijgc-2023-004531}
}

RIS

TY  - JOUR
TI  - The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial design.
AU  - Inci MG
AU  - Sehouli J
AU  - Schnura E
AU  - Lee M
AU  - Roll S
AU  - Reinhold T
AU  - Klews J
AU  - Kaufner L
AU  - Niggemann P
AU  - Groeben H
AU  - Toelkes J
AU  - Reisshauer A
AU  - Liebl M
AU  - Daehnert E
AU  - Zimmermann M
AU  - Knappe-Drzikova B
AU  - Rolker S
AU  - Nunier B
AU  - Algharably E
AU  - Pirmorady Sehouli A
AU  - Zwantleitner L
AU  - Krull A
AU  - Heitz F
AU  - Ataseven B
AU  - Chekerov R
AU  - Harter P
AU  - Schneider S
PY  - 2023
JO  - International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
DO  - 10.1136/ijgc-2023-004531
UR  - https://doi.org/10.1136/ijgc-2023-004531
ER  - 

APA

MG, I., J, S., E, S., M, L., S, R., T, R., J, K., L, K., P, N., H, G., J, T., A, R., M, L., E, D., M, Z., B, K., S, R., B, N., E, A., A, P. S., L, Z., A, K., F, H., B, A., R, C., P, H., & S, S. (2023). The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial design.. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. https://doi.org/10.1136/ijgc-2023-004531

Source records